InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool

IRVINE, Calif., Sept. 9, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announces the launch of Morpheus8 Cool, the next evolution of its renowned Morpheus8 technology. Available exclusively on the new expandable Morpheus8MAX platform, Morpheus8 Cool advances radiofrequency (RF) microneedling with enhanced comfort, precision, control, and safety.

Recognized as the world's #1 RF microneedling procedure, Morpheus8 is establishing a new industry standard with Morpheus8 Cool. The new handpiece and large-surface cooling tip feature game-changing Cool Comfort Technology, intelligently managing the thermal profile to elevate the treatment experience.  Morpheus8 Cool also features a new interactive user interface for enhanced control and safety.  Practitioners can select Guided Mode, with preset, clinically effective parameters that support consistent, repeatable outcomes, or Manual Mode for fully customizable settings.

"Developed in response to feedback from our providers, Guided Mode within the Morpheus8MAX platform offers greater versatility across their practices," said Dr. Michael Kreindel, InMode Chief Technology Officer and co-founder. "Its intuitive design gives practitioners greater flexibility to tailor treatments to each patient's skin concerns and anatomy while delivering the remarkable results patients and providers have come to expect from Morpheus8."

"Morpheus8 Cool addresses an important challenge in aesthetics: how to make a proven, successful technology even better," said Dr. Eran Krieger, Chief Medical Officer at InMode. "By cooling the skin's surface while treating the targeted tissue, we preserve the remodeling effect without compromising treatment. We are not changing the treatment—we are elevating the patient experience."

"The excitement surrounding Morpheus8 Cool was undeniable when we introduced it at our Insider Summit in Las Vegas," said Michael Dennison, InMode President, North America. "Providers immediately recognized the value of greater comfort, precision, and control, and the enthusiastic response reinforced the strong demand for this next evolution of Morpheus8 technology."

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Press Contact:
Behrman Cesa Communications
[email protected]

Investor Contact:
MS-IR LLC
Miri Segal – Scharia
[email protected]

SOURCE InMode Ltd.